GlassScriptPhysician profile
Beth A Malizia
NPI 1740233352
$10,859.49
in general payments reported to CMS, 2019-2025
12 companies · $422 in 2025
The $422 reported for 2025 was more than what 84% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,051 · 2020: $1,935 · 2021: $801 · 2022: $349 · 2023: $238 · 2024: $64.26 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374 · Honoraria: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.52 |
| Honoraria | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $9,454.31 | 2019-2024 | Menopur |
| Meditrina | $388.34 | 2023-2025 | |
| Medtronic, INC. | $372.20 | 2021-2023 | Truclear |
| Hologic Sales and Service, LLC | $218.90 | 2022-2023 | Btx |
| Merck Sharp & Dohme LLC | $101.73 | 2019-2020 | |
| Organon LLC | $97.28 | 2021-2024 | |
| Emd Serono, INC. | $89.45 | 2019-2020 | |
| Kerecis Limited | $48.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Covidien LP | $46.24 | 2019-2020 | |
| Boston Scientific Corporation | $16.28 | 2020 | |
| Coopersurgical, INC. | $13.22 | 2022 | |
| Minerva Surgical, INC | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Malizia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.